Heart Failure in Sub-Saharan Africa: Current and Future Systems of Care
Sub-Saharan Africa is undergoing rapid demographic and epidemiological transitions, fuelled by urbanisation, lifestyle changes and ageing populations. Consequently, the continent is faced with a ballooning burden of both communicable and non-communicable diseases (NCDs). Cardiovascular diseases are the leading cause of NCD-related mortality in SSA, with heart failure (HF) being the common phenotypic manifestation, afflicting a relatively younger population compared to other world regions. Even though the burden of HF is expected to double by 2030, HF systems of care remain poor in sub-Saharan Africa. Poor outcomes are especially aggravated by systemic barriers including under-resourced and siloed prevention, diagnostic, treatment and research efforts. Integrating HF care delivery through a systems approach and addressing risk factor prevention, screening and treatment across various tiers of care is crucial in abating the increasing burden of HF and NCDs. Further, a more patient-centred system of care that strengthens health financing, policies and system capabilities should be adopted to improve HF care and outcomes in sub-Saharan Africa.
Authors
- Krishna Udayakumar (ORCID: https://orcid.org/0000-0001-8954-4343)
- G. Titus K. Ngeno (ORCID: https://orcid.org/0000-0003-4507-4006)
- Dzifa Ahadzi (ORCID: https://orcid.org/0000-0002-2696-3695)
- Victor M. Wauye
Institutions
- Moi University (KE)
- Duke University (US)
- Tamale Teaching Hospital (GH)
- Duke Institute for Health Innovation (US)
Publication Details
- Journal
- Journal of Asian Pacific Society of Cardiology
- Published
- 2025-05-06
- DOI
- https://doi.org/10.15420/japsc.2024.37
- Primary Topic
- Global Health and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- United States Agency for International Development
- Bill and Melinda Gates Foundation
- Rockefeller Foundation
- Conrad N. Hilton Foundation
- Amgen
- Pfizer
- AstraZeneca
- World Health Organization
- Dalio Foundation
- Grand Challenges Canada
- Astellas Pharma
- Pfizer Foundation
- Beijing Friendship Hospital, Capital Medical University